THC Stock Analysis: Buy, Sell, or Hold?
THC - Tenet Healthcare Corporation New
$203.72
12.52 (6.55%)
▲
5d:
+10.75%
30d:
+24.52%
90d:
+7.07%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 24, 2026
20d
Smart Money Distribution
None View Scanner →
Strength: 7.1/10
Get Alerted When THC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: THC is 9.1% above its trading range ($186.76). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: THC is 9.1% above its trading range ($186.76). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$11.78
Based on -36.2% avg growth
INTRINSIC VALUE TODAY
$7.32
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: THC is currently trading at $203.72, which is considered extended relative to its 30-day fair value range of $166.44 to $186.76. The stock's valuation (Forward PE: 11.5) is in line with its historical norms (11.5). At these levels, the market is pricing in 0.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, THC is in a downtrend. The price is approaching resistance at $182.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $243.19 (+19.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, THC is in a downtrend. The price is approaching resistance at $182.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $243.19 (+19.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$166.44 -
$186.76
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
49.5%
Protect Your Profits
THC is technically overbought (RSI 70). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+9.1% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.5%)
- BULLISH: Trading below Wall St target ($243.19)
- NEUTRAL: Market pricing in 0.1% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$166.44 -
$186.76
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$157.58
Resistance Level
$182.69
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.50
Wall Street Target
$243.19
(+19.4%)
Revenue Growth (YoY)
2.8%
Earnings Growth (YoY)
87.6%
Profit Margin
7.9%
Valuation Premium vs History
+0.1% premium
PE vs Historical
11.5 vs 11.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.1%
(market-implied from PE analysis)
1-Year Target
$203.92
(+0%)
2-Year Target
$204.13
(+0%)
3-Year Target
$204.33
(+0%)
3-Yr Target (if PE normalizes)
(PE: 12→12)
$204.39
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -76.3%)
$377.17
(+85%)
Base:
(SPY PE: 11.5, Growth: -76.3%)
$199.09
(-2%)
Bear:
(PE: 9.8, Growth: -76.3%)
$169.23
(-17%)
📈
Valuation based on Current Earnings
Trailing PE: 9.94 | Current EPS (TTM): $19.23
Bull Case
$193.81
(-5%)
Analyst growth -7.9%, PE expands to 10.9
Base Case
$176.19
(-14%)
Market implied -7.9%, PE stable at 9.9
Bear Case
$130.02
(-36%)
Severe decline -20.0%, PE contracts to 8.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 03, 2026 6:20 PM ET
Data refreshes hourly during market hours. Next update: 7:20 PM
Data refreshes hourly during market hours. Next update: 7:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is THC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Paola M Arbour
SELL
6500 shares
2026-03-11
Thomas W Arnst
SELL
8000 shares
2026-03-09
R. Scott Ramsey
SELL
8017 shares
2026-03-02
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$500 | 66 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 53 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 60 BUY |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 61 BUY |
Advanced THC Option Strategies
Professional options setups generated by AI based on today's THC price and gamma walls.
